Active Penny Stocks in the News
PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
Netlist, Inc. (NASDAQ: NLST) reached up 25.31% in morning trading to $3.07 with 4M shares traded. Netlist, Inc. designs and manufactures high-performance, logic-based memory subsystems for the server and high-performance computing and communications markets. Netlist, Inc. (NASDAQ: NLST) announced, as required by NASDAQ Listing Rule 5635(c)(4), that it has made certain stock option grants to new employees.
For detailed quote and full article http://www.pennytrader.com/quotes/NLST.php
Intelligroup, Inc. (OTC Bulletin Board: ITIG) was up 26.65% in morning trading to $4.61 with 860K shares traded. Intelligroup is a global provider of innovative consulting, technology, and outsourcing services. NTT DATA Corporation (Tokyo Stock Exchange, First Section: 9613) ("NTT DATA"), the Japan-based leading IT services company, and Intelligroup, Inc. (OTC Bulletin Board:ITIG.ob - News) ("Intelligroup"), a US-based IT services company, today announced that they have entered into a merger agreement pursuant to which NTT DATA will acquire Intelligroup for approximately US $199 million through an all-cash tender offer, followed by a second-step merger to acquire all remaining shares at the same price paid in the tender offer.
For detailed quote and full article http://www.pennytrader.com/quotes/ITIG.php
Cell Therapeutics, Inc. ("CTI") (Nasdaq: CTIC) was up 14.70% in morning trading to $.515 with 16M shares traded. Cell Therapeutics, Inc. is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that the Italian Medicines Agency ("AIFA"), the national authority responsible for drug regulation in Italy, has approved the facility at NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences Srl, in Nerviano, Italy) for the production of CTI's drug candidate pixantrone. CTI is in the process of preparing a Marketing Authorization Application ("MAA") in the European Union for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").
For detailed quote and full article http://www.pennytrader.com/quotes/CTIC.php
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
For complete disclosure information go to http://www.pennytrader.com/disclosure/
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/
